Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Eur J Immunol 41:24942498
Community reports put the prevalence at roughly 10 to 15 percent, almost always tied to evening injection timing
Pharmaceutical Packaging Configuration: 600mg/ 10 /box Stability: 36-month shelf life (40/75%RH validated) Storage: Store below 25, protected from light Compliance: 21 CFR Part 211 packaging standards Professional Usage Guide Reconstitution: Dissolve with pH 6.80.2 solvent (30s dissolution) Administration: IM/IV injection per patient condition Regimen: 1 weekly 6 weeks Compatibility: Can be co-administered with 10% vitamin C (98.7% absorption rate) Safety: Phase III: 0.33% AE incidence (n=300) Medical Advisory & Disclaimer Notice: For licensed practitioner use only
This article walks through three things in order: the no-human-data reality and what preclinical work does and doesn't establish, the theoretical oncological concern tied to the HGF/c-Met pathway, and the anecdotal adverse effects community sources describe
Peptides 24(2):307311
